DE602004009917D1 - Zwischenprodukt für die herstellung von pioglitazon - Google Patents
Zwischenprodukt für die herstellung von pioglitazonInfo
- Publication number
- DE602004009917D1 DE602004009917D1 DE602004009917T DE602004009917T DE602004009917D1 DE 602004009917 D1 DE602004009917 D1 DE 602004009917D1 DE 602004009917 T DE602004009917 T DE 602004009917T DE 602004009917 T DE602004009917 T DE 602004009917T DE 602004009917 D1 DE602004009917 D1 DE 602004009917D1
- Authority
- DE
- Germany
- Prior art keywords
- pioglitazone
- manufacture
- intermediate product
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 title 2
- 239000013067 intermediate product Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229960005095 pioglitazone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200301075A ES2219180B1 (es) | 2003-05-09 | 2003-05-09 | Compuesto intermedio util para la preparacion de pioglitazona. |
| ES200301075 | 2003-05-09 | ||
| PCT/ES2004/070031 WO2004099147A1 (es) | 2003-05-09 | 2004-05-04 | Compuesto intermedio útil para la preparación de pioglitazona |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE602004009917D1 true DE602004009917D1 (de) | 2007-12-20 |
| DE602004009917T2 DE602004009917T2 (de) | 2008-08-21 |
Family
ID=33427384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004009917T Expired - Fee Related DE602004009917T2 (de) | 2003-05-09 | 2004-05-04 | Zwischenprodukt für die herstellung von pioglitazon |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7375231B2 (de) |
| EP (1) | EP1623977B1 (de) |
| AR (1) | AR044267A1 (de) |
| AT (1) | ATE377588T1 (de) |
| CA (1) | CA2525190A1 (de) |
| DE (1) | DE602004009917T2 (de) |
| ES (2) | ES2219180B1 (de) |
| PL (1) | PL1623977T3 (de) |
| PT (1) | PT1623977E (de) |
| WO (1) | WO2004099147A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1957476A1 (de) * | 2005-11-23 | 2008-08-20 | AstraZeneca AB | L-alaninderivate |
| US20090062267A1 (en) * | 2007-01-29 | 2009-03-05 | Astrazeneca Ab | L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS |
| WO2008125811A1 (en) * | 2007-04-11 | 2008-10-23 | Astrazeneca Ab | N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS |
| WO2012177956A1 (en) * | 2011-06-23 | 2012-12-27 | Metabolic Solutions Development Comapny, Llc | Ppar-sparing compounds for use in the treatment of diabetes and other metabolic diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| JPH08325263A (ja) * | 1995-05-31 | 1996-12-10 | Sumitomo Metal Ind Ltd | 新規2−アミノ−3−フェニルプロピオン酸誘導体 |
| JP2000344748A (ja) * | 1999-03-29 | 2000-12-12 | Welfide Corp | 3−芳香族置換プロピオン酸またはアクリル酸化合物 |
| AU2002311057A1 (en) * | 2001-04-26 | 2002-11-11 | Leciva, A.S. | Method for obtaining pioglitazone as an antidiabetic agent |
-
2003
- 2003-05-09 ES ES200301075A patent/ES2219180B1/es not_active Expired - Fee Related
-
2004
- 2004-05-04 DE DE602004009917T patent/DE602004009917T2/de not_active Expired - Fee Related
- 2004-05-04 PT PT04731028T patent/PT1623977E/pt unknown
- 2004-05-04 CA CA002525190A patent/CA2525190A1/en not_active Abandoned
- 2004-05-04 AT AT04731028T patent/ATE377588T1/de not_active IP Right Cessation
- 2004-05-04 EP EP04731028A patent/EP1623977B1/de not_active Expired - Lifetime
- 2004-05-04 US US10/555,659 patent/US7375231B2/en not_active Expired - Fee Related
- 2004-05-04 ES ES04731028T patent/ES2297415T3/es not_active Expired - Lifetime
- 2004-05-04 WO PCT/ES2004/070031 patent/WO2004099147A1/es not_active Ceased
- 2004-05-04 PL PL04731028T patent/PL1623977T3/pl unknown
- 2004-05-07 AR ARP040101563A patent/AR044267A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2219180B1 (es) | 2006-03-01 |
| US7375231B2 (en) | 2008-05-20 |
| ES2297415T3 (es) | 2008-05-01 |
| PT1623977E (pt) | 2008-01-22 |
| AR044267A1 (es) | 2005-09-07 |
| US20070083050A1 (en) | 2007-04-12 |
| ATE377588T1 (de) | 2007-11-15 |
| ES2219180A1 (es) | 2004-11-16 |
| EP1623977B1 (de) | 2007-11-07 |
| CA2525190A1 (en) | 2004-11-18 |
| WO2004099147A1 (es) | 2004-11-18 |
| PL1623977T3 (pl) | 2008-04-30 |
| DE602004009917T2 (de) | 2008-08-21 |
| EP1623977A1 (de) | 2006-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE434598T1 (de) | Zwischenprodukte für die herstellung von dioxan-2-alkylcarbamaten | |
| ATE447564T1 (de) | Zwischenprodukte für die herstellung von trans-5- chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenzä , 3:6,7üoxepinoä4,5-cüpyrrol | |
| DE602004000740D1 (de) | Herstellung von Nuten | |
| ATE348100T1 (de) | Zwischenprodukten für die herstellung von pyridazinon aldose reductase inhibitoren. | |
| NO20053796D0 (no) | Process for the production of particles | |
| SE0301552L (sv) | New product | |
| ATE343605T1 (de) | Zusammensetzungen zur herstellung von aminoplasterzeugnissen | |
| DE60323456D1 (de) | Herstellung von Nanopartikeln | |
| IS2674B (is) | Aðferð við framleiðslu á handhverfulega hreinu mírtasapíni | |
| ITBO20030349A1 (it) | Procedimento e macchina per la produzione di scatole di | |
| DE602004004777D1 (de) | Kontinuierliches verfahren für die herstellung von polyamiden | |
| DE60238030D1 (de) | Katalysatorzusammensetzung für die Herstellung von Polyolefinen | |
| DE602004009917D1 (de) | Zwischenprodukt für die herstellung von pioglitazon | |
| ATE474824T1 (de) | Herstellung von olefinen | |
| DE602005017357D1 (de) | Überwachungseinrichtung für die herstellung von zusammensetzungen | |
| ITMI20030346A1 (it) | Procedimento per la produzione di mesitilene. | |
| ATE401299T1 (de) | Verfahren für die herstellung von hydroxyethylaminen | |
| DE602004008092D1 (de) | Pressblasmaschine für die herstellung von hohlen glaswaren | |
| DE60224968D1 (de) | Prozess für die Herstellung von 5-Arylpentanolen | |
| ATE534624T1 (de) | Verfahren und zwischenprodukte für die herstellung von n-(1-benzhydryl-azetidin-3-yl)-n- phenyl-methylsulphonamid-derivaten | |
| AT501391A5 (de) | Formwerkzeug zur herstellung von formsteinen | |
| DE10391072D2 (de) | Presswerkzeug für die Herstellung von Formteilen | |
| DE602004013311D1 (de) | Neue zwischenprodukte für die herstellung therapeutisch wirksamer imidazopyridine | |
| FI20031249A0 (fi) | Menetelmä valssimaisten tuotteiden valmistukseen | |
| DE60319439D1 (de) | Verfahren zur herstellung von langkettigen alkoholen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |